Endoglin (CD105) and vascular endothelial growth factor as prognostic markers in colorectal cancer

Modern Pathology

Volumn 17, Issue 2, 2004, Pages 197-203

  Saad, Reda S ^a   Liu, Yulin L ^b   Nathan, Girija ^b   Celebrezze, James ^b   Medich, David ^b   Silverman, Jan F ^b  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ALLEGHENY GENERAL HOSPITAL   (United States)

Author keywords

Angiogenesis; Cancer colon; CD31; Endoglin

Indexed keywords

CD31 ANTIGEN; ENDOGLIN; VASCULOTROPIN; CELL SURFACE RECEPTOR; ENG PROTEIN, HUMAN; LEUKOCYTE ANTIGEN; TUMOR MARKER; VASCULAR CELL ADHESION MOLECULE 1; VASCULOTROPIN A;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER METASTASIS; LYMPH NODE METASTASIS; MALE; MICROVASCULATURE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; BIOSYNTHESIS; COLORECTAL TUMOR; COMPARATIVE STUDY; LIVER TUMOR; METABOLISM; METASTASIS; MIDDLE AGED; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; RETROSPECTIVE STUDY; VASCULARIZATION;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD; COLORECTAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; RECEPTORS, CELL SURFACE; RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL; VASCULAR CELL ADHESION MOLECULE-1; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 4344658425     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.3800034     Document Type: Article

References (48)

1. Lindmark G, Gerdin B, Pahlman L, et al. Prognostic predictors in colorectal cancer. Dis Colon Rectum 1994;37:1219-1227.
2. Compton C, Fenoglio-Preiser CM, Pettigrew N, et al. American Joint Committee on Cancer Prognostic Factors Consensus Conference: Colorectal Working Group. Cancer 2000;88:1739-1757.
3. Sokmen S, Sarioglu S, Fuzun M, et al. Prognostic significance of angiogenesis in rectal cancer: a morphometric investigation. Anticancer Res 2001;21:4341-4348.
4. Wolmark N, Fisher B, Wieand HS. The prognostic value of the modifications of the Dukes' C class of colorectal cancer: an analysis of the NSABP trials. Ann Surg 1986;302:115-122.
5. Folkman J. What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 1990;82:4-6.
6. Folkman J. Angiogenesis and breast cancer. J Clin Oncol 1994;12:441-443.
7. Weidner N. Intratumor microvessel density as a prognostic factor in cancer. Am J Pathol 1995;147:9-19.
8. Polverini PJ, Leibovich SJ. Induction of neovascularization in vivo and endothelial proliferation in vitro by tumor associated macrophages. Lab Invest 1984;51:635-642.
9. Zatterstrom UK, Brun E, Willen R, et al. Tumor angiogenesis and prognosis in squamous cell carcinoma of the head and neck. Head Neck 1995;17:312-318.
10. Srivastava A, Laidler P, Davies RP, et al. The prognostic significance of tumor vascularity in intermediate thickness (0.76-4.O mm thick) skin melanoma. A quantitative histologic study. Am J Pathol 1988;133:419-423.
11. Macchiarini P, Fontani G, Hardin MJ, et al. Relation of neovascularization to metastasis of non-small cell lung cancer. Lancet 1992;340:145-146.
12. Weidner N, Semple JP, Welch WR, et al. Tumor angiogenesis and metastasis: Correlation in invasive breast carcinoma. N Engl J Med 1991;324:1-8.
13. Dickinson AJ, Fox SB, Persad RA, et al. Quantification of angiogenesis as an independent predictor of prognosis in invasive bladder carcinoma. Br J Urol 1994;74:762-766.
14. Weidner N, Carroll PR, Flax J, et al. Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am J Pathol 1993;143:401-409.
15. Wiggins DL, Granai CO, Steinhoff MM, et al. Tumor angiogenesis as a prognostic factor in cervical carcinoma. Gynecol Oncol 1995;56:353-356.
16. Abulafia O, Triest WE, Sherer DM. Angiogenesis in primary and metastatic epithelial ovarian carcinoma. Am J Obstet Gynecol 1997;177:541-547.
17. Bossi P, Viale G, Lee AK, et al. Angiogenesis in colorectal tumors: microvessel quanitation in adenomas and carcinomas with clinicopathological correlations. Cancer Res 1995;55:5049-5053.
18. Pietra N, Sarli L, Caruana P, et al. Is tumor angiogenesis a prognostic factor in patients with colorectal cancer and no involved nodes? Eur J Surg 2000;166:552-556.
19. Saclarides TJ, Speziale NJ, Drab E, et al. Tumor angiogenesis and rectal carcinoma. Dis Colon Rectum 1994;37:921-926.
20. Frank RE, Saclarides TJ, Leurgans S, et al. Tumor angiogenesis as predictor of recurrence and survival in patients with node-negative colon cancer. Ann Surg 1995;222:695-699.
21. Bodey B, Bodey Jr B, Siegel SE, et al. Over-expression of endoglin (CD 105): a marker of breast carcinoma-induced neovascularization. Anticancer Res 1998;18:3621-3628.
22. Brewer CA, Setterdahl JJ, Li MJ, et al. Endoglin expression as a measure of microvessels density in cervical cancer. Obstet Gynecol 2000;96:224-228.
23. Choi HJ, Hyun MS, Jung GJ, et al. Tumor angiogenesis as a predictor in colorectal carcinoma with special reference to mode of metastasis and recurrence. Oncology 1998;55:575-581.
24. Saad RS, Jasnosz KM, Silverman JF. Endoglin (CD105) expression in endometrial carcinoma. Int J Gynecol Pathol 2003;22:248-253.
25. Vermeulen PB, Gasparini G, Fox SB, et al. Quantification of angiogenesis in solid human tumors: an international consensus on the methodology and criteria of evaluation. Eur J Cancer 1996;32:2474-2484.
26. Takebayashi Y, Akiyama S, Yamada K, et al. Angiogenesis as an unfavorable prognostic factor in human colorectal carcinoma. Cancer 1996;78:226-231.
27. Engel CJ, Bennet ST, Chambers AF, et al. Tumor angiogenesis predicts recurrence in invasive colorectal cancer when controlled for Dukes staging. Am J Surg Pathol 1996;20:1260-1265.
28. Tomisaki S, Ohno S, Ichiyoshi Y, et al. Microvessel quantification and its possible relation with liver metastases in colorectal cancer. Cancer 1996;77:1722-1728.
29. Wang JM, Kumar S, Pye D, et al. Breast carcinoma: comparative study of tumor vasculature using two endothelial cell markers. J Natl Cancer Inst 1994;86:386-388.
30. Parums DV, Cordell JL, Micklem K, et al. JC70: a new monoclonal antibody that detects vascular endothelium associated antigen on routinely processed tissue sections. J Clin Pathol 1990;43:752-757.
31. Akagi K, Ikeda Y, Sumiyoshi Y, et al. Estimation of angiogenesis with anti-CDl05 immunostaining in the process of colorectal cancer development. Surgery 2002;131:S109-S113.
32. Guidi AJ, Fischer L, Harris JR, et al. Microvessel density and distribution in ductal carcinoma in situ of the breast. J Natl Cancer Inst 1994;86:614-619.
33. Mietinnen M, Lindenmayer AE, Chaubal A. Endothelial cell markers CD31, CD34, BNH9 antibody to H- and Y- antigens: evaluation of their specificity and sensitivity in the diagnosis of vascular tumors and comparison with von Willebrand factor. Mod Pathol 1994;7:82-90.
34. Giatromanolaki A, Sivridis E, Koukourakis MI, et al. Intratumoral angiogenesis: a new prognostic indicator for stage I endometrial adenocarcinoma? Oncol Res 1999;11:205-212.
35. Smith-McCune KK, Weidner N. Demonstration and characterization of the angiogenic properties of cervical dysplasia. Cancer Res 1994;54:800-804.
36. Kuzu I, Bicknell R, Harris AL, et al. Heterogeneity of vascular endothelial cells with revelance to diagnosis of vascular tumors. J Clin Pathol 1992;45:143-148.
37. Lindenmayer AE, Miettinen M. Immunophenotypic features of uterine stromal cells. CD34 expression in endocervical stroma. Virchows Arch 1995;426:457-460.
38. Saad RS, Dabbs DJ. Endoglin, CD31 and CD34 expression in the breast cancer. Mod Pathol 2001;14:35A (Abstract).
39. Tanigawa N, Amaya H, Matsumura M, et al. Tumor angiogenesis and mode of metastases in patients with colorectal cancer. Cancer Res 1997;57:1043-1046.
40. Giatromanolaki A, Stathopoulos GP, Tsiobanou E, et al. Combined role of angiogenesis, bcl-2 and p53 expression in the prognosis of colorectal cancer. Cancer 1999;86:1421-1430.
41. Vermeulen PB, van den Eynden GG, Huget P, et al. Prospective study of intratumoral microvessel density, p53 expression and survival in colorectal cancer. Br J Cancer 1999;79:316-322.
42. Burrows FJ, Derbyshire EJ, Tazzari PL, et al. Upregulation of endoglin on vascular endothelial cells in human solid tumors: implications for diagnosis and therapy. Clin Cancer Res 1995;1:1623-1634.
43. Claffey KP, Robinson GF. Regulation of VEGF/VPF expression in tumor cells: consequences for tumor growth and metastasis. Cancer Metast Rev 1996;15:165-176.
44. Kang SM, Maeda K, Onoda N. Combined analysis of p53 and vascular endothelial growth factor expression in colorectal carcinoma for determination of tumor vascularity and liver metastasis. Int J Cancer 1997;74:502-507.
45. Lee JC, Chow NH, Wang ST, et al. Prognostic value of vascular endothelial growth factor expression in colorectal cancer patients. Eur J Cancer 2000;36:748-753.
46. Ishigami SI, Arii S, Furutani M, et al. Predictive value of vascular endothelial growth factor (VEGF) for metastasis and prognosis of human colorectal cancer. Br J Cancer 1998;78:1379-1384.
47. Takahashi Y, Tucker SL, Kitadai Y. Vessel counts and expression of vascular endothelial growth factors as prognostic factors in node-negative colon cancer. Arch Surg 1997;132:541-546.
48. Chung YS, Maeda K, Swa M. Prognostic value of angiogenesis in gastrointestinal tumors. Eur J Cancer 1996;32A:2501-2505.